GlycoMimetics Historical Cash Flow
| GLYC Stock | USD 0.32 0.03 10.34% |
Analysis of GlycoMimetics cash flow over time is an excellent tool to project GlycoMimetics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 110.7 K or Depreciation of 217.6 K as it is a great indicator of GlycoMimetics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining GlycoMimetics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether GlycoMimetics is a good buy for the upcoming year.
GlycoMimetics |
About GlycoMimetics Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in GlycoMimetics balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which GlycoMimetics's non-liquid assets can be easily converted into cash.
GlycoMimetics Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by GlycoMimetics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of GlycoMimetics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from GlycoMimetics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into GlycoMimetics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlycoMimetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For information on how to trade GlycoMimetics Stock refer to our How to Trade GlycoMimetics Stock guide.At present, GlycoMimetics' Begin Period Cash Flow is projected to increase significantly based on the last few years of reporting. The current year's Depreciation is expected to grow to about 217.6 K, whereas Change In Cash is projected to grow to (5.8 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Capital Expenditures | 14.9K | 84.2K | 21.4K | 20.3K | Depreciation | 264.6K | 207.1K | 153.3K | 217.6K |
GlycoMimetics cash flow statement Correlations
Click cells to compare fundamentals
GlycoMimetics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
GlycoMimetics cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (51.7M) | (21.2M) | (46.8M) | (42.4M) | (6.1M) | (5.8M) | |
| Stock Based Compensation | 6.2M | 6.9M | 6.1M | 3.9M | 3.6M | 3.6M | |
| Free Cash Flow | (52.1M) | (39.3M) | (57.5M) | (46.5M) | (34.9M) | (36.6M) | |
| Change In Working Capital | (1.2M) | 3.9M | (1.2M) | (4.7M) | (2.6M) | (2.4M) | |
| Begin Period Cash Flow | 209.9M | 158.2M | 137.0M | 90.3M | 47.9M | 82.2M | |
| Other Cashflows From Financing Activities | 412.9K | 319.3K | 25.0K | (84.2K) | 116.5K | 110.7K | |
| Depreciation | 279.2K | 270.8K | 264.6K | 207.1K | 153.3K | 217.6K | |
| Capital Expenditures | 144.9K | 68.5K | 14.9K | 84.2K | 21.4K | 20.3K | |
| Total Cash From Operating Activities | (52.0M) | (39.2M) | (57.5M) | (46.5M) | (34.9M) | (36.6M) | |
| Net Income | (57.9M) | (51.0M) | (63.4M) | (46.7M) | (36.9M) | (38.7M) | |
| Total Cash From Financing Activities | 412.9K | 18.1M | 10.7M | 4.2M | 28.8M | 32.8M | |
| End Period Cash Flow | 158.2M | 137.0M | 90.3M | 47.9M | 41.8M | 39.7M | |
| Change To Liabilities | 1.5M | 1.4M | 17.7K | (1.1M) | (1.0M) | (972.5K) | |
| Other Non Cash Items | 620.1K | 680.8K | 749.0K | 828.5K | 864.9K | 908.1K | |
| Sale Purchase Of Stock | 113.9M | 129.4M | 412.9K | 18.1M | 16.3M | 15.5M | |
| Total Cashflows From Investing Activities | (144.9K) | (68.5K) | (14.9K) | (84.2K) | (96.8K) | (101.7K) | |
| Cash And Cash Equivalents Changes | 83.9M | 86.0M | (51.7M) | (21.2M) | (19.0M) | (18.1M) | |
| Cash Flows Other Operating | (2.3M) | (487.5K) | (2.1M) | 3.2M | 3.7M | 3.9M | |
| Change To Operating Activities | 21.3K | 3.3M | (1.2M) | (3.5M) | (3.2M) | (3.0M) | |
| Change To Netincome | 6.2M | 6.9M | 6.8M | 4.7M | 5.4M | 4.9M | |
| Investments | (144.9K) | (68.5K) | (14.9K) | (84.2K) | (20.6K) | (21.6K) | |
| Issuance Of Capital Stock | 9.6M | 17.8M | 10.7M | 4.2M | 32.9M | 27.1M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether GlycoMimetics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of GlycoMimetics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Glycomimetics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Glycomimetics Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlycoMimetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For information on how to trade GlycoMimetics Stock refer to our How to Trade GlycoMimetics Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlycoMimetics. If investors know GlycoMimetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlycoMimetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.62) | Quarterly Revenue Growth (1.00) | Return On Assets (0.59) | Return On Equity (1.04) |
The market value of GlycoMimetics is measured differently than its book value, which is the value of GlycoMimetics that is recorded on the company's balance sheet. Investors also form their own opinion of GlycoMimetics' value that differs from its market value or its book value, called intrinsic value, which is GlycoMimetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlycoMimetics' market value can be influenced by many factors that don't directly affect GlycoMimetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlycoMimetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if GlycoMimetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlycoMimetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.